A global initiative to understand Parkinson's disease better
ENIGMA Parkinson’s Initiative: A Global Initiative for Parkinson’s Disease
This study is looking at how Parkinson's disease affects the brain by using special imaging techniques, and it's inviting people with Parkinson's from around the world to help us understand the disease better and find ways to track its progression.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10916343 on NIH RePORTER |
What this research studies
This research focuses on Parkinson's disease, a progressive neurodegenerative condition affecting millions worldwide. By utilizing advanced brain imaging techniques, the study aims to identify objective metrics that can gauge the progression of the disease and its impact on brain structures. The initiative seeks to gather data from a diverse, global population to enhance the understanding of Parkinson's and improve the reproducibility of findings. Patients will be involved in a coordinated effort to analyze brain imaging data and identify factors influencing disease severity.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Parkinson's disease, particularly those in diverse geographic locations.
Not a fit: Patients with other neurodegenerative diseases or those without a Parkinson's diagnosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment strategies for Parkinson's disease.
How similar studies have performed: Previous ENIGMA initiatives have successfully utilized a similar global consortium approach to study other mental health conditions, indicating a promising potential for this research.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Thompson, Paul M — University of Southern California
- Study coordinator: Thompson, Paul M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.